Sanofi SA (France) Today
| SAN Stock | EUR 93.17 2.30 2.53% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Sanofi SA is trading at 93.17 as of the 24th of November 2024, a 2.53% up since the beginning of the trading day. The stock's open price was 90.87. Sanofi SA has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sanofi SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of August 2024 and ending today, the 24th of November 2024. Click here to learn more.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was incorporated in 1994 and is headquartered in Paris, France. SANOFI operates under Drug ManufacturersGeneral classification in France and is traded on Paris Stock Exchange. The company has 1.25 B outstanding shares. More on Sanofi SA
Moving together with Sanofi Stock
Moving against Sanofi Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sanofi Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sanofi SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sanofi SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Sanofi SA (SAN) is traded on Euronext Paris in France and employs 91,573 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 110.83 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sanofi SA's market, we take the total number of its shares issued and multiply it by Sanofi SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sanofi SA operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.25 B outstanding shares.
Sanofi SA has accumulated about 9.72 B in cash with 10.53 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.76.
Check Sanofi SA Probability Of Bankruptcy
Ownership AllocationSanofi SA shows a total of 1.25 Billion outstanding shares. 30% of Sanofi SA outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sanofi Ownership Details
Sanofi SA Risk Profiles
Although Sanofi SA's alpha and beta are two of the key measurements used to evaluate Sanofi SA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8251 | |||
| Standard Deviation | 1.13 | |||
| Variance | 1.27 | |||
| Risk Adjusted Performance | (0.07) |
Sanofi Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sanofi SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Sanofi SA Corporate Management
Elected by the shareholders, the Sanofi SA's board of directors comprises two types of representatives: Sanofi SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sanofi. The board's role is to monitor Sanofi SA's management team and ensure that shareholders' interests are well served. Sanofi SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sanofi SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JeanBaptiste Chatillon | Ex CFO | Profile | |
| Roy Papatheodorou | Gen VP | Profile | |
| Josephine Fubara | Chief Care | Profile | |
| Paul Hudson | CEO Director | Profile | |
| Bruno Mnard | Chief officer | Profile | |
| Pierre Chancel | Sr Marketing | Profile | |
| Laurent Gilhodes | Principal Accounting | Profile |
Other Information on Investing in Sanofi Stock
Sanofi SA financial ratios help investors to determine whether Sanofi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sanofi with respect to the benefits of owning Sanofi SA security.